Shareholder Information

NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS OF SOLVENTIS SV, SA

Pursuant to the agreement adopted by the Board of Directors of SOLVENTIS, SV, SA dated March 27, 2026, and in compliance with the provisions of the Articles of Association and in accordance with the current Capital Companies Law, the shareholders are hereby summoned to the Ordinary General Meeting to be held at 12:00 on April 30, 2026, in Madrid, Paseo de la Castellana 60, 4th floor right, in first call, and in the same place and time the following day in second call.

The matters to be discussed at the meeting will be those contained in the following

ORDER OF THE DAY

1. Ratification of the valid constitution of the general shareholders' meeting, the agenda and the positions of president and secretary.
2. Examination, and where appropriate, approval of the Annual Accounts and management report of SOLVENTIS SV SA corresponding to the financial year ended on December 31, 2025.
3. Review, and where appropriate, approval of the proposal for the application of results for the 2025 financial year.
4. Examination, and where appropriate, approval of the Annual Accounts and management report of the SOLVENTIS GROUP (Solventis SV SA and Dependent Companies) corresponding to the financial year ended on December 31, 2025.
5. Censorship, and where applicable, approval of the company's management for the financial year ending December 31, 2025.
6. Authorization to the members of the Board of Directors to perform their functions for the purposes of those provided for in Article 230 of the Capital Companies Law.
7. Termination, resignation and, where applicable, appointment of directors. Resolutions to be adopted, if any.
8. Revocation and, where applicable, appointment of the auditing entity.
9. Delegation of powers for the formalization, execution and registration, where applicable, of the agreements adopted.
10. Questions and answers.
11. Drafting, reading and approval, if applicable, of the minutes of the meeting

From the date of publication of this Notice and in compliance with the provisions of Articles 197, 272 and 287 of the Capital Companies Law, shareholders may examine at the registered office (in Madrid, Paseo de la Castellana, No. 60, 4th floor right) the full text of the proposals, all the documents that must be submitted to the approval of the Board, the corresponding Reports of the Directors, Annual Accounts and Management Report, as well as obtain from the Company, immediately and free of charge, the sending or delivery of all the aforementioned documents.

In Madrid, on March 30, 2026.
Mr. Alberto Moro Suárez, Chairman of the Board of Directors.

SOLVENTIS EOS, SICAV, SA

The Board of Directors has agreed to convene the shareholders of the company to the Ordinary and Extraordinary General Meeting of Shareholders to be held at the company's registered office located in Madrid, Paseo de la Castellana, number 60, 4th floor, on June 27, 2025, at 10:00 a.m. in first call or, in second call, on June 30, 2025, at the same place and time, in order to deliberate and resolve on the matters included in the following

ORDER OF THE DAY

1. Examination and approval, where applicable, of the Annual Accounts (balance sheet, profit and loss account, statement of changes in equity and notes) and Management Report, corresponding to the financial year ending December 31, 2024.
2. Review and approval, if applicable, of the management of the Board of Directors during the 2024 financial year.
3. Examination and approval, if applicable, of the proposal for the application of results for the 2024 financial year.
4. Examination, approval and, where applicable, ratification of the management carried out by the Management Company.
5. Termination, resignation and, where applicable, appointment of directors. Resolutions to be adopted, if any.
6. Revocation and, where applicable, appointment of the auditing entity.
7. Authorization to the Board of Directors for the derivative acquisition of own shares under the provisions of Article 146 and related articles of the Capital Companies Law.
8. Related party transactions and conflict of interest. Agreements to be adopted, if any.
9. Delegation of powers for the formalization, execution and registration, where applicable, of the agreements adopted.
10. Questions and answers.
11. Drafting, reading and approval, if applicable, of the minutes of the meeting.

In accordance with the provisions of the Spanish Companies Act (Articles 197, 272, and 287), from the date of this notice, any shareholder may obtain from the company, immediately and free of charge, the documents to be submitted for approval at the General Meeting, the management report, and the audit report. Shareholders may also examine, at the company's registered office, the full text of any proposed amendments to the Articles of Association and the report on those amendments, and request the delivery or free shipment of said documents. Shareholders are also reminded of their right to attend the meeting, which they may exercise in accordance with the company's Articles of Association and applicable law.

In Madrid on May 22, 2025. The Non-Director Secretary of the Board of Directors. Mr. Carlos Masdevall Garçon.

RG 27, SICAV, SA

The Board of Directors has agreed to convene the shareholders of the company to the Ordinary and Extraordinary General Meeting of Shareholders to be held at the company's registered office located in Barcelona, ​​Avenida Diagonal, number 682, 5th floor A, on June 27, 2025, at 17:00 p.m. in first call or, in second call, on June 30, 2025, at the same place and time, in order to deliberate and resolve on the matters included in the following

ORDER OF THE DAY

1. Examination and approval, where applicable, of the Annual Accounts (balance sheet, profit and loss account, statement of changes in equity and notes) and Management Report, corresponding to the financial year ending December 31, 2024.
2. Review and approval, if applicable, of the management of the Board of Directors during the 2024 financial year.
3. Examination and approval, if applicable, of the proposal for the application of results for the 2024 financial year.
4. Examination, approval and, where applicable, ratification of the management carried out by the Management Company.
5. Termination, resignation and, where applicable, appointment of directors. Resolutions to be adopted, if any.
6. Revocation and, where applicable, appointment of the auditing entity.
7. Authorization to the Board of Directors for the derivative acquisition of own shares under the provisions of Article 146 and related articles of the Capital Companies Law.
8. Related party transactions and conflict of interest. Agreements to be adopted, if any.
9. Delegation of powers for the formalization, execution and registration, where applicable, of the agreements adopted.
10. Question time
11. Drafting, reading and approval, if applicable, of the minutes of the meeting.

In accordance with the provisions of the Spanish Companies Act (Articles 197, 272, and 287), from the date of this notice, any shareholder may obtain from the company, immediately and free of charge, the documents to be submitted for approval at the General Meeting, the management report, and the audit report. Shareholders may also examine, at the company's registered office, the full text of any proposed amendments to the Articles of Association and the report on those amendments, and request the delivery or free shipment of said documents. Shareholders are also reminded of their right to attend the meeting, which they may exercise in accordance with the company's Articles of Association and applicable law.

In Barcelona on May 23, 2025. The non-Director Secretary of the Board of Directors. Mr. Carlos Masdevall Garçon.

SOLVENTIS CRONOS RF INTERNACIONAL, FI (ABSORBING FUND)
ALTAIR ABSOLUTE RETURN, FI (ABSORBED FUND)

Merger by Acquisition Announcement

In compliance with the provisions of Article 26, paragraph 4, of Law 35/2003, of November 4, on Collective Investment Institutions (hereinafter, the “LIIC”), it is hereby made public that Solventis, Sociedad Gestora de Instituciones de Inversión Colectiva, Sociedad Anónima, as the Management Company of the funds indicated below, has adopted the merger agreement by absorption of Altair Retorno Absoluto, FI (absorbed fund) by Solventis Cronos RF Internacional, FI (absorbing fund), with dissolution and without liquidation of the absorbed fund and with block transfer of all its assets and liabilities to the absorbing fund, the latter succeeding, in universal title, to all the rights and obligations of the absorbed fund.

The Spanish National Securities Market Commission (CNMV) has authorized the merger project, effective December 5, 2025. This project can be consulted at the CNMV and at the registered office of the Management Company. Furthermore, participants in the participating funds will receive more detailed information about the merger individually.

In accordance with Article 12, second paragraph, of the LIIC, and given that none of the funds have redemption fees, participants may redeem their units at any time with the net asset value on the date of the request. The merger will be executed forty days after the date of this announcement or the date of individual notification to participants, whichever is later.

Madrid, December 9, 2025.- The Chairman of the Board of Directors of Solventis, SGIIC, SA Ramiro Martínez-Pardo del Valle.

View Merger Project (PDF)

ALTAIR INVESTMENTS II, FI (ABSORBING FUND)
SOLVENTIS ZEUS GLOBAL HERITAGE, FI (ABSORBED FUND)

Merger by Acquisition Announcement

In compliance with the provisions of Article 26, paragraph 4, of Law 35/2003, of November 4, on Collective Investment Institutions (hereinafter, the “LIIC”), it is hereby made public that Solventis, Sociedad Gestora de Instituciones de Inversión Colectiva, Sociedad Anónima, as the Management Company of the funds indicated below, has adopted the merger agreement by absorption of Solventis Zeus Patrimonio Global, FI (absorbed fund) by Altair Inversiones II, FI (absorbing fund), with dissolution and without liquidation of the absorbed fund and with transfer in block of all its assets and liabilities to the absorbing fund, the latter succeeding, in universal title, to all the rights and obligations of the absorbed fund.

The Spanish National Securities Market Commission (CNMV) has authorized the merger project, effective December 5, 2025. This project can be consulted at the CNMV and at the registered office of the Management Company. Furthermore, participants in the participating funds will receive more detailed information about the merger individually.

In accordance with Article 12, second paragraph, of the LIIC, and given that none of the funds have redemption fees, participants may redeem their units at any time with the net asset value on the date of the request. The merger will be executed forty days after the date of this announcement or the date of individual notification to participants, whichever is later.

Madrid, December 9, 2025.- The Chairman of the Board of Directors of Solventis, SGIIC, SA Ramiro Martínez-Pardo del Valle.

View Merger Project (PDF)